In
First in Dallas: Corindus – Robotic Assisted Device
®
A “first” in fiscal year 2017,
Corindus® Vascular Robotics
CorPath was introduced in
the cath labs. Cardiologists
on the medical staffs at Baylor
Hamilton Heart and Vascular
Hospital, together with Baylor
Heart and Vascular Services
at Fort Worth, became a
part of a small group in the
state of Texas to use robotic-
assisted technology to perform
coronary angioplasties or place cardiac stents. The
Corindus Vascular Robotics CorPath System, the first and
only FDA-cleared medical device to bring robotic-assisted
precision to coronary angioplasty procedures, was purchased
and placed into use at three Baylor Scott & White Health
facilities – the only locations in North Texas.*
With this addition to the cardiac cath labs at Baylor
Hamilton Heart and Vascular Hospital, angioplasty
procedures can now be performed using the enhanced
visualization of the X-ray images with robotic precision.
And with the skill of the clinical team and interventional
cardiologists on the medical
staff, Baylor Hamilton Heart
and Vascular Hospital has
become a training site for
interventional cardiologists
from across the United States.
“Robotics offers physicians
and patients a minimally
invasive technology that
improves the precision of
stent and balloon placements
and reduces radiation exposure during the procedure for
physicians,” says Jeffrey Schussler, MD, FACC, FSCAI,
FSSCCT, FACP, an interventional cardiologist and
medical director of the cardiovascular intensive care unit,
Baylor Hamilton Heart and Vascular Hospital.
Although angioplasty remains one of the most frequently
performed procedures in the United States, with more
than 900,000 cases annually, the procedure itself has
continued largely unchanged for decades. This new
system is advanced technology available to interventional
cardiologists and catheterization labs.
Percutaneous Coronary Intervention
32
Baylor Hamilton Heart and Vascular Hospital is a well-
known destination for interventional cardiology procedures
with a reputation for clinical quality and good outcomes
documented through data analyses by national registries. In
fact, physicians from throughout the region send patients to
cardiologists on the medical staff at Baylor Hamilton Heart
and Vascular Hospital for angioplasty, also known as PCI,
to unblock narrowed coronary arteries without performing
surgery. PCI is a treatment option for patients with simple
and complex ischemic cardiovascular disease, and patients
benefit from on-campus research through Baylor Hamilton
Heart and Vascular Hospital’s interventional program.
4,185
1,732
Cardiac
catheterization
cases (FY17)
Total PCI
cases † (FY17)
Percutaneous Coronary
Intervention** † BHVH U.S.
Rate
Lipid lowering medications at
discharge 97.7% 94.7%
Therapy with aspirin, P2Y12
inhibitor, and statin at discharge
following PCI in eligible patients 99.6% 95.1%
Angiotensin converting enzyme
(ACE) inhibitors 61% 47.3%
92.9% 79.2%
PCI length of stay <1 2
Complications** † BHVH U.S.
Rate
Percent total with stroke 0.2% 0.3%
Percent total with any adverse
events 3.2% 5.3%
ACE or ARB among patients with
EF <40%
*At the time of printing
**NCDR through Q1 2017
† Baylor Hamilton Heart and Vascular Hospital/Dallas location only